CLN5 and glioma: Yet, counter-intuitively, several studies have shown that the treatment of glioma cells with BMPs leads to the reduction of their proliferation rate in vitro and in murine xenograft models, with this effect being attributed to a pro-differentiating effect and/or the promotion of quiescent state [88,89,90,91,92,93].